Skip to main content

Respiratory Diseases and Clinical Management

A comprehensive guide to understanding and managing common respiratory diseases, including infectious conditions like tuberculosis and pneumonia, obstructive diseases such as COPD and asthma, and cardiovascular/pulmonary complications like cor pulmonale and pulmonary embolism. It covers pathophysiology, clinical manife

Save this reading to your study set

Sign up free

The respiratory system is a complex network responsible for gas exchange, maintaining acid-base balance, and facilitating cellular respiration. When this system is compromised by infection, inflammation, or obstruction, patients can rapidly progress from mild dyspnea to life-threatening respiratory failure. Understanding the pathophysiology, clinical manifestations, and therapeutic interventions for these conditions is essential for effective nursing management and patient outcomes.

Infectious Respiratory Diseases

Tuberculosis (TB)

Tuberculosis is a communicable disease caused by Mycobacterium tuberculosis. It is particularly prevalent among high-risk populations, including those in crowded environments like prisons or nursing homes, and healthcare workers.

  • Signs and Symptoms: Symptoms often appear insidiously and include a low-grade fever, fatigue, weight loss, night sweats, and a cough that may be nonproductive or produce mucopurulent sputum. Hemoptysis (coughing up blood) is a significant indicator.
  • Diagnosis: Screening involves the Mantoux skin test (intradermal injection). A result >10 mm> 10\text{ mm} suggests active TB. Confirmation requires three sputum cultures obtained 8 to 24 hours apart that are positive for Acid-Fast Bacilli (AFB).
  • Management: Treatment requires long-term pharmacologic therapy (3–6 months) using first-line agents: Isoniazid, Rifampin, Pyrazinamide, and Ethambutol.
    • Isoniazid can be used as a prophylactic agent for patients with unknown exposures.
    • Rifampin may turn urine and tears orange; patients should be warned.
    • Compliance: Due to severe side effects, "Directly Observed Therapy" (DOT) is used, where staff observe the patient taking medication to ensure adherence.
  • Duration of Therapy: If sputum cultures are negative after eight weeks, four additional months of therapy are required. If the culture remains positive, seven additional months are needed.

Pneumonia and Influenza

Pneumonia is an inflammation of the lung parenchyma caused by bacteria, viruses, fungi, or mycobacteria. Influenza is a viral infection (types A, B, and C) that can lead to pneumonia as a major complication.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.